Access to biospecimens and/or clinical–molecular data collected through PanCAN’s Precision Promise adaptive clinical trial platform, to advance pancreatic cancer research by validating biomarkers, discovering determinants of response/resistance, defining subtypes, and identifying therapeutic targets or combinations.
Eligibility Criteria:
-
Applicants must have been affiliated with the PanCAN Precision Promise platform. For eligibility questions, contact the PanCAN Research Grants Department (email only).
Funding Details:
-
Limited research funding is available via Catalyst Awards; budgets are flexible, generally around USD 300,000 total for projects up to 2 years.
-
Samples and data are limited and released through a peer-review process until exhausted; priority for analytically sound clinical validation and generation of novel biomedical/molecular data that will serve the research community.
Deadline:
-
Applications due: November 3, 2025, 9:00 a.m. PT / 12:00 p.m. ET.
-
Decisions: late December 2025 / early January 2026.
Where to go for further information:
-
Inventory/questions: email [email protected] before applying to discuss available specimens/data and fit.
-
Application portal: ProposalCentral.